[Retracted] Apatinib plus Radiotherapy on the Expression of CEA and VEGF in Advanced Oligometastatic Non-Small-Cell Lung Cancer

<table class="table-group" id="tab2"><tr><td><table class="table"><tr><td class="thead-hr" colspan="6"><hr/></td></tr><tr class="thead"><td class="align_left"> </td><td class="align_center">CR</td><td class="align_center">PR</td><td class="align_center">SD</td><td class="align_center"><i>P</i>D</td><td class="align_center">ORR</td></tr><tr><td class="thead-hr" colspan="6"><hr/></td></tr><tr><td class="align_left">Control group (<i>n</i> = 32)</td><td class="align_center">6</td><td class="align_center">6</td><td class="align_center">9</td><td class="align_center">11</td><td class="align_center">21 (65.62%)</td></tr><tr><td class="align_left">Study group (<i>n</i> = 32)</td><td class="align_center">7</td><td class="align_center">15</td><td class="align_center">7</td><td class="align_center">3</td><td class="align_center">29 (90.63%)</td></tr><tr><td class="align_left"><i>χ</i>2</td><td class="align_center"> </td><td class="align_center"> </td><td class="align_center"> </td><td class="align_center"> </td><td class="align_center">5.851</td></tr><tr><td class="align_left"><i>P</i></td><td class="align_center"> </td><td class="align_center"> </td><td class="align_center"> </td><td class="align_center"> </td><td class="align_center">0.016</td></tr><tr class="table-tr"><td colspan="6"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>Comparison of clinical efficacy (n, %).</div>

Evidence-Based Complementary and Alternative Medicine

tab2

Table 2

Table 2: [Retracted] Apatinib plus Radiotherapy on the Expression of CEA and VEGF in Advanced Oligometastatic Non-Small-Cell Lung Cancer 